Bayview Legacy LLC trims Arteris (AIP) stake via 10b5-1 stock sales

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of the company’s common stock under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025.

The LLC sold 47,244 shares on February 9, 2026 at a weighted average price of $15.2053 per share and 2,756 shares on February 10, 2026 at a weighted average price of $15.0322 per share. After these transactions, it indirectly held 9,349,071 Arteris shares, with voting and dispositive power deemed to be held by manager K. Charles Janac.

Insights

Corporate governance and insider transactions analyst

Planned insider sales by major holder; modest stake reduction.

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., executed open-market sales totaling 50,000 shares over two days at weighted average prices around $15 per share. The filing states these trades were made under a Rule 10b5-1 trading plan adopted on March 5, 2025.

Use of a 10b5-1 plan typically indicates pre-scheduled selling rather than opportunistic trading, which can reduce concerns about timing. Following the sales, Bayview Legacy still holds 9,349,071 shares, so the reduction is small relative to its remaining indirect position.

The filing also explains that K. Charles Janac, as manager of Bayview Legacy, is deemed to have voting and dispositive power over these shares and has filed a separate Form 4 in his individual capacity. Subsequent company filings may provide additional context on any future plan-related transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last) (First) (Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL CA 95008

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		S(1)(2)		47,244	D	$15.2053(3)	9,351,827	I	See Footnote(4)
Common Stock	02/10/2026		S(1)(2)		2,756	D	$15.0322(5)	9,349,071	I	See Footnote(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.51 to $15.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.85 to $15.22 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Bayview Legacy, LLC report for Arteris (AIP)?

Bayview Legacy, LLC reported selling 50,000 Arteris common shares in open-market trades. The sales occurred on February 9 and 10, 2026, at weighted average prices of $15.2053 and $15.0322 per share, respectively, as disclosed in the Form 4 filing.

How many Arteris (AIP) shares did Bayview Legacy, LLC retain after these sales?

After the reported transactions, Bayview Legacy, LLC beneficially owned 9,349,071 Arteris common shares indirectly. The filing notes that K. Charles Janac, as manager of Bayview Legacy, is deemed to have voting and dispositive power over this remaining share position.

Were Bayview Legacy, LLC’s Arteris (AIP) share sales under a 10b5-1 plan?

Yes. The filing states the transactions were made under a Rule 10b5-1 trading plan adopted on March 5, 2025. Such plans pre-schedule trades, aiming to separate trading decisions from day-to-day information or market conditions affecting Arteris.

What prices did Bayview Legacy, LLC receive for the Arteris (AIP) shares sold?

The Form 4 reports weighted average sale prices. On February 9, 2026, shares sold at $15.2053 within a $14.51–$15.46 range. On February 10, 2026, shares sold at $15.0322 within a $14.85–$15.22 range, across multiple individual trades each day.

Who controls Bayview Legacy, LLC’s Arteris (AIP) holdings according to the filing?

According to the disclosure, K. Charles Janac is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over the shares it beneficially owns. He has separately filed a Form 4 in his individual capacity reporting the same transactions.

What is Bayview Legacy, LLC’s relationship to Arteris (AIP)?

Bayview Legacy, LLC is identified as a 10% owner of Arteris, Inc. in the filing. This makes it a significant shareholder subject to Section 16 reporting requirements, which mandate timely Form 4 filings when it buys or sells Arteris common stock.